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Abstract: Fructose-sweetened liquid consumption is associated with fatty liver and oxidative 
stress. In rodent models of fructose-mediated fatty liver, protein consumption is decreased. 
Additionally, decreased sulfur amino acid intake is known to cause oxidative stress. Studies 
were designed to test whether oxidative stress in fructose-sweetened liquid-induced fatty 
liver is caused by decreased ad libitum solid food intake with associated inadequate sulfur 
amino acid intake. C57BL6 mice were grouped as: control (ad libitum water), fructose  
(ad libitum 30% fructose-sweetened liquid), glucose (ad libitum 30% glucose-sweetened 
water) and pair-fed (ad libitum water and sulfur amino acid intake same as the fructose 
group). Hepatic and plasma thiol-disulfide antioxidant status were analyzed after five weeks. 
Fructose- and glucose-fed mice developed fatty liver. The mitochondrial antioxidant protein, 
thioredoxin-2, displayed decreased abundance in the liver of fructose and glucose-fed mice 
compared to controls. Glutathione/glutathione disulfide redox potential (EhGSSG) and 
abundance of the cytoplasmic antioxidant protein, peroxiredoxin-2, were similar among 
groups. We conclude that both fructose and glucose-sweetened liquid consumption results 
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in fatty liver and upregulated thioredoxin-2 expression, consistent with mitochondrial 
oxidative stress; however, inadequate sulfur amino acid intake was not the cause of this 
oxidative stress. 
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1. Introduction 
Consumption of reﬁned sugars has increased over the past decades [1,2] and fructose, in particular, 
has been implicated as a contributing factor in the development of metabolic diseases [3]. These diseases 
include conditions such as obesity, dyslipidemia, insulin resistance, diabetes, high blood pressure [4–13], 
and non-alcoholic fatty liver disease [14–18]. The etiology of fructose-mediated metabolic disturbances 
is not completely understood; however, it is likely due to a multifactorial disease process [4,5,9,19,20]. 
Fructose consumption and its metabolic alterations, including fatty liver, have been associated with 
oxidative stress [21–33], which may play role in the pathogenesis of these conditions. 
In animal models, fructose-sweetened beverage consumption is associated with decreased food and 
protein intake [34–36]. Therefore, inadequate ingestion of macronutrients and energy from solid foods 
may be important in the metabolic alterations attributed to fructose-sweetened beverages [20,37–43]. 
In rodents, when fructose-sweetened liquid is provided ad libitum, liquid intake increases and solid 
food consumption decreases, while total energy intake is maintained at a level comparable to 
controls [34,44,45]. This resultant decrease in solid food results in decreased protein consumption and 
insufficient intake of non-essential and essential amino acids, which includes the sulfur amino acids, 
i.e., cysteine (Cys) and methionine.  
All cells have thiol-dependent antioxidant systems that are critical in redox regulation of cellular 
processes, like gene transcription, and protection against oxidative stress [46]. Major thiol-containing 
redox couples (GSH/GSSG, thioredoxin (Trx) and peroxiredoxin (Prx)) contain Cys as a central thiol 
and oxidation of these residues provide useful markers of oxidative stress [47]. In humans, Cys 
deficiency can lead to plasma oxidative stress [48], and in rodents, dietary sulfur amino acid 
insufficiency causes plasma and tissue level oxidative stress [49,50], as shown by steady-state redox 
potentials (Eh) for GSH/GSSG and Cys/CySS redox couples. Because fructose-sweetened beverages 
decrease dietary sulfur amino acid intake and sulfur amino acid insufficiency causes oxidative stress, it 
is possible that decreased sulfur amino acid intake may contribute to oxidative stress observed in 
fructose-induced fatty liver. Therefore, the purpose of this study was to determine if oxidative stress 
associated with fructose-induced fatty liver was due to decreased sulfur amino acid intake. In the 
experimental design, pair-feeding of mice with the amount of solid food consumed by the fructose 
group resulted in substantial energy deficiency in the pair-fed group. Despite this difference in energy 
intake, the pair-fed group did not show hepatic oxidative stress either in terms of thiol/disulphide 
levels or mitochondrial thioredoxin-2 or cytoplasmic/nuclear peroredoxin-2 levels. Thus, the results 
show that fructose- or glucose-induced fatty liver is not an artefact due to oxidative stress caused by 
insufficient protein intake.  
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2. Materials and Methods 
2.1. Animals and Feeding Protocol 
This protocol was approved by the Institutional Animal Care and Use Committee at Emory 
University and performed according to NIH guidelines. The study outlined below was repeated in two 
separate experiments to confirm findings. Results were similar for both experiments and combined  
for presentation.  
Five week-old C57BL6 male mice (N = 39) were purchased from Charles River Laboratory. 
Anhydrous dextrose and D-fructose were purchased from Harlan Teklad. Mice were housed in 
individual cages in a pathogen-free barrier facility. During an initial acclimatization period of 1 week, 
all mice received water ad libitum and solid food ad libitum (LabDiet-5001, AIN 93M, PMI Nutrition 
International). Methionine (Met) and Cys content of the diet were 0.67% and 0.31%, respectively. At  
6 weeks of age, mice were allocated to four groups: control (ad libitum water and ad libitum solid 
food; n = 10), fructose (ad libitum 30% fructose-sweetened water (w/v) and ad libitum solid food;  
n = 11), glucose (ad libitum 30% dextrose-sweetened water (w/v) and ad libitum solid food; n = 10) 
and a pair fed group (ad libitum water, pair fed to fructose for solid food intake of F; n = 8). The  
pair-fed animals were started on dietary intervention one day after starting the fructose-fed mice and 
the mean daily individual food consumption of the fructose group was fed to individual pair-fed mice. 
Mice were examined daily for signs of dehydration and distress. Body weight and water and food 
consumption, were measured every other day. After 5 weeks, at sacriﬁce, animals were anesthetized 
with 80 mg/kg ketamine and 6 mg/kg xylazine i.p. Blood was collected from a cheek and 50 µL of 
plasma was processed for Cys, CySS, GSH and GSSG analyses by high performance liquid 
chromatography (HPLC) as previously outlined [49,50]. Portions of liver (approximately 5 mg) were 
immediately added to preservation solution for redox measurements [49,50]. Additional samples were 
snap frozen in liquid nitrogen or placed in OCT compound for cryosectioning and Oil Red O staining 
and stored at −80 °C. Because of a laboratory error, samples for Oil Red O staining were not available 
for the glucose-treated group. Because glucose-induced fatty liver is established in the literature [29,51] 
and confirmed by the triglyceride measurements obtained in the present studies, the experiment was 
not repeated to obtain this additional control. 
2.2. Analytical Methods 
Plasma and hepatic Cys, CySS, GSH and GSSG concentrations were measured using HPLC. 
Methods were adopted from Jones et al. and Nkabyo et al. [49,52,53]. Protein concentration of liver 
samples was measured using the Bradford assay. EhCyss and EhGSSG were calculated using the 
Nernst Equation. Percent of oxidized thiol (% CySS and % GSSG) was calculated with respect to thiol 
concentration (oxidized + reduced + mixed disulfide Cys-GSH). Plasma Met concentration was 
measured as an additional indicator of plasma sulfur amino acid levels using liquid chromatography 
mass spectrometry (LC-FTMS) with electrospray ionization in positive ion mode essentially as 
described by Johnson et al. [54]. Plasma samples with visible hemolysis were excluded. Plasma 
extracts were separated using anion exchange chromatography and detected using LTQ-FT mass 
spectrometer (Thermo Fisher Scientiﬁc, San Jose, CA). Met (m/z 149.0510) was quantified relative to Nutrients 2011, 3  
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a stable isotopic internal standard. Hepatic triglycerides (TG) were assayed using a TG quantification kit 
(BioVision, CA; cat# K622-100). Liver samples (approximately 100 mg) were collected into 1 mL of  
5× Triton-X solution, homogenized and processed per manufacturer’s instructions. For TG 
quantification, absorbance at 570 nm was calibrated to reference standards and data were expressed  
as nmol/100 mg of liver tissue.  
2.3. Western Blot Analyses 
Hepatic protein abundance of thioredoxin-2 (Trx2) and peroxiredoxin-2 (Prx2) was analysed by 
Western blot. Liver (approximately 5 mg) was washed with ice cold PBS and immediately placed in 
300 µL lysis buffer (1% NP-40, 0.5% Triton X-100, 50 mM Tris, 2 mM EDTA, 500 mM NaCl, 
protease inhibitor; pH 7.6), sonicated, vortexed, and centrifuged. Supernatant was used for protein 
quantification and Western blot analysis. 
For all Western blots, 20 µg of protein was loaded in each well, separated using 15% SDS 
polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. After blocking, the 
membranes were incubated with primary antibodies specific to Trx-2 [55], Prx2 (Abcam16748),   
COX-IV (Abcam16056 as a mitochondrial control protein) or β-actin (Sigma-Aldrich A5441) for 1 h 
followed by the secondary antibody (IRDyeTM-800-conjugated anti-rabbit or anti-mouse antibody 
(Rockland Immuno chemicals, Gilbertsville, PA)) for 1 h. Protein bands were visualized by the 
Odyssey system (LiCor, Lincoln, NE) and quantified by densitometry. 
2.4. Thiobarbituric Acid Reactive Substances Assay 
A small amount of frozen liver tissue was placed in a 1.5 mL tube containing 200 μL of RIPA 
buffer. The samples were then sonicated for approximately 10 s to homogenize the tissue. Insoluble 
debris was pelleted via centrifugation and 100 μL of supernantant was added to 200 μL of 10% 
trichloroacetic acid. The samples were incubated on ice for 15 min and the precipitated protein was 
pelleted by centrifugation. 200 μL of supernatant was added to 200 μL of 0.67% (w/v) 2-thiobarbituric 
acid and incubated for 15 min at 100 °C. Samples were cooled to room temperature and absorbance at 
532 nm was read on a microplate reader.  
2.5. Oil Red O Staining 
Liver tissue preserved in OCT compound was cryosectioned into 10 µM sections, mounted onto 
microscope slides and stored at −10 °C until staining. Slides were allowed to acclimate to room 
temperature for approximately 10–15 min prior to staining. Tissue was then fixed in 10% neutral 
buffered formalin for 5 min and briefly washed in water. The slides were then rinsed in 60% 
isopropanol and placed into freshly prepared Oil Red O working solution. Slides were allowed to stain 
for 15 min at room temperature. After staining, slides were rinsed with 60% isopropanol and the nuclei 
were lightly stained with hematoxylin stain (approx. 5 dips). Lastly, the slides were washed 3 times in 
water and coverslips were applied using aqueous mounting media. The slides were then visualized on a 
light microscope at 100× magnification. 
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2.6. Statistical Analysis 
Data are expressed as mean ± SEM. Statistical analysis was performed using SPSS 16.0 (IBM, 
Chicago, IL). ANOVA with Tukey’s post-hoc test was used to compare the groups. p ≤ 0.05 was 
considered statistically significant. 
3. Results 
3.1. Fatty Liver 
Fructose and glucose fed mice developed fatty liver as evidenced by significantly higher hepatic TG 
content (75 ± 4 nmol/100 mg and 70 ± 5 nmol/100 mg, respectively) compared to control and pair-fed 
mice (44 ± 1 nmol/100 mg and 41 ± 2 nmol/100 mg), respectively (each p < 0.05). To confirm  
the development of hepatic steatosis, frozen liver sections were stained with Oil Red O to visualize 
lipid accumulation (Figure 1). Results from fructose-fed mice confirmed fatty liver; samples from 
glucose-treated mice were not available, but glucose-induced fatty liver has been previously 
established [29,51] and confirmed in the present study by the TG measurements. Together, these data 
show that both fructose and glucose cause fatty liver. 
Figure 1. Oil Red O staining of frozen liver sections from control, pair-fed and   
fructose-fed mice. These sections are visualized at 100× magnification. The red staining 
corresponds to lipids and the blue stain corresponds to nuclei, respectively. 
 
3.2. Animal Characteristics 
Body weight and food consumption data are detailed in Table 1.  
Initial body weights were similar for all groups. At the end of dietary treatment, the fructose and 
glucose-fed groups had a 10% and 25% weight gain respectively, compared to control. The pair-fed 
group lost weight during the course of the study because the design resulted in a relatively severe 
calorie restriction. However, these mice remained active and did not show any signs of distress. 
Consumption of fructose or glucose supplemented water resulted in a 38% and 54% decrease in solid 
food (and thus sulfur amino acid intake) consumption respectively, compared to control. Dietary liquid 
consumption was different across all the groups. Fructose-fed and glucose-fed mice had 42% and 98% 
higher, while the pair-fed mice had 56% lower liquid intake respectively compared to controls. Total 
CONTROL PAIR-FED FRUCTOSE
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energy intake (solid food + liquid) in fructose-fed (18 ± 1 kcal/day) and glucose-fed (19 ± 1 kcal/day) 
mice was similar to control mice (16 ± 1 kcal/day) (Table 1). As liquid consumption in the fructose 
and glucose groups increased, solid food intake decreased and total energy intake was similar 
compared to controls. Glucose-fed mice consumed about 30% more energy (11.4 ± 1 kcal/day) from 
liquid than fructose-fed mice (8.1 ± 1 kcal/day). Energy intake for mice in the pair-fed group   
(10 ± 0 kcal/day) was 52–62% of other groups. 
Table 1. Animal weights and dietary intake 
#. 
Parameters 
Control 
n = 10 
Fructose 
n = 11 
Glucose 
n = 10 
Pair fed 
n = 8 
p 
† 
Initial weight (g)  20.1 ± 0.1 
a 20 ± 0.3 
a  19.9 ± 0.3 
a  19.6 ± 0.3 
a 0.7 
Final weight (g)  25.5 ± 0.3 
a 28.1 ± 0.6 
b  31.8 ± 0.6 
c  17.1 ± 0.2 
d <0.001
Solid food intake (gm/day)  3.9 ± 0.2 
a  2.4 ± 0.3 
b  1.8 ± 0.2 
b  2.4 ± 0 
b <0.001
Liquid intake (mL/day)  4.8 ± 0.3 
a  6.8 ± 0.2 
b  9.5 ± 0.2 
c  2.1 ± 0.1 
d <0.001
Cysteine intake (mg/day)  12.2 ± 0.7 
a 7.5 ± 0.9 
b  5.7 ± 0.5 
b  7.5 ± 0 
b <0.001
Methionine intake (mg/day)  26.4 ± 1.5 
a 16.3 ± 20 
b  12.2 ± 1.2 
b  16.3 ± 0 
b <0.001
Total caloric intake (kcal/day)  16.0 ± 1.0 
a 18.0 ± 1.0 
a  19.0 ± 1.0 
a  10.0 ± 0 
b <0.001
a,b,c,d Different superscripted letters indicate statistically significant (p < 0.05) difference between 
groups; 
# Data expressed as mean ± SEM; 
† ANOVA. 
3.3. Plasma Sulfur Amino Acids  
Plasma methionine levels were measured using LC-FTMS. The ion intensity of methionine in both 
fructose-fed and glucose-fed mice was similar to controls even though sulfur amino acid intake was 
lower (Figure 2). Pair-fed animals displayed methionine levels that were significantly lower than the 
other groups. Additionally, plasma Cys (Table 2) showed a trend similar to methionine and was also 
lower in pair-fed animals compared to other groups. 
Figure 2. Plasma methionine concentration as measured by LC-FTMS. The data is expressed 
as integral ion intensity relative to internal standard. Pair-fed mice had significantly decreased 
plasma methionine concentration compared to other groups. Different superscripted letters 
(a,b) indicate statistically significant differences among respective groups. 
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Table 2. High Performance Liquid Chromatography data of plasma and liver thiols 
#. 
Antioxidant thiols 
Control 
n = 10 
Fructose 
n = 11 
Glucose 
n = 10 
Pair fed 
n = 8 
p 
† 
Plasma         
Cys (µM)  18.2 ± 2.0 
a  17.1 ± 1.0 
a  13.2 ± 2.0 
a,b  9.1 ± 1.0 
b 0.002
CySS (µM)  40.4 ± 2.0  40.9 ± 3.0  43.7 ± 3.0  33.4 ± 2.0  0.06 
GSH (µM)  26.4 ± 5.0 
a  17.2 ± 2.0  20.7 ± 2.0  10.5 ± 2.0 
b 0.005
GSSG (µM)  1.6 ± 0.3  1.3 ± 0.3.0  1.3 ± 0.2  0.7 ± 0.2  0.2 
Total Cys (µM)  114.1 ± 4.0 
a  109.4 ± 8.0 
a  113.8 ± 3.0 
a  81.0 ± 5.0 
b 0.004
Total GSH (µM)  44.8 ± 7.0 
a  30.4 ± 3.0 
a,b  36.5 ± 4.0 
a  17.0 ± 2.0 
b 0.001
Liver         
Cys (µM)  9.9 ± 2.0  7.2 ± 2.0  17.1 ± 9.0  11.8 ± 2.0  0.5 
CySS (µM)  38.3 ± 7.0 
a  34.6 ± 6.0 
a,b  41.7 ± 8.0 
a  10.9 ± 2.0 
b 0.01 
GSH (µM)  1884 ± 149.0 
a 1642 ± 137.0 
a  1432 ± 177 
a,b 982 ± 63 
b 0.002
GSSG (µM)  81.9 ± 13.0 
a  52.3 ± 5.0 
a,b  40.8 ± 7.0 
b  40.5 ± 4.0 
b 0.004
Total Cys (µM)  126.1 ± 15.0 
a  104.5 ± 14.0 
a,b 116.6 ± 18.0 
a 57.4 ± 5.0 
b 0.01 
Total GSH (µM)  2087.2 ± 144 
a 1774.5 ± 142 
a  1530 ± 202 
a,b 1087 ± 66 
b 0.001
a,b Different superscripted letters indicate statistically significant (p < 0.05) difference between 
groups; 
# Data expressed as mean ± SEM; 
† ANOVA. 
3.4. Plasma Oxidative Stress Indices  
Even with the decreased sulfur amino acid intake due to fructose and glucose, plasma Cys, total Cys 
(Cys + CySS + Cys-GSH) and total GSH concentration (GSH + GSSG + Cys-GSH) were similar to 
control mice (Table 2). In contrast, GSH level was lower in fructose-fed and glucose-fed mice 
compared to control. Interestingly, the fructose and pair-fed groups had the same sulfur amino acid 
intake, but the pair-fed animals had lower plasma Cys, total Cys, GSH and total GSH. Pair-fed animals 
also had an increased % CySS (Figure 3) indicating greater systemic oxidative stress. GSH/GSSG 
ratio, Cys/CySS ratio and % GSSG were not different across groups (data not shown). Plasma EhCySS 
was more oxidized (more positive Eh) in pair-fed mice compared to control and fructose groups 
(Figure 4). EhGSSG values did not show significant differences between groups.  
3.5. Hepatic Oxidative Stress  
Similar to data from the plasma, hepatic Cys and GSH content was not different in the control, 
fructose and glucose groups, but was decreased in the pair-fed animals (Table 2). Thiobarbituric acid 
reactive substances (TBARS) in the liver, a common metric of oxidative stress and lipid peroxidation, 
showed that TBARS was increased due to fructose treatment but this was not statistically significant 
(Figure 5). Importantly, the pair-fed group did not show evidence of increase. In contrast to the plasma 
data described above, the relative concentrations of CySS and Cys shifted towards a more reduced 
state (Figure 4). GSH/GSSG ratio, Cys/CySS ratio and % GSSG did not differ across the groups  
(data not shown). 
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Figure 3. % CySS in plasma and liver. CySS was measured as percent of total Cys pool  
(Cys, CySS and Cys-GSH). Different letters (a,b) indicate statistically significant differences 
among respective groups. In the pair-fed group, plasma % Cyss was significantly increased 
while hepatic % Cyss was decreased, indicating oxidation of plasma but not liver.  
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Figure 4. Cys/CySS redox potential (EhCySS) in plasma and liver. EhCySS is calculated 
using Nernst equation and expressed in mV. Different letters (a,b) indicate statistically 
significant difference among respective groups. In the pair fed group, the EhCySS was 
oxidized in plasma, while reduced in liver compared to other groups, indicating differential 
plasma but not hepatic oxidative stress.  
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Figure 5. Results of thiobarbituric acid reactive substances (TBARS) assays shows that 
fructose and glucose feeding do not result in significant increases in hepatic lipid 
peroxidation. Data was analyzed via one-way ANOVA (p = 0.417). 
 
In contrast to plasma, hepatic % CySS was lower and EhCySS was more reduced in the pair-fed 
group (Figure 3). EhGSSG in control, fructose, glucose and pair-fed groups were not significantly 
different. Thus, even though there is an indication of systemic oxidative stress in plasma, the results do 
not provide evidence for hepatic oxidative stress as measured by the tissue TBARS, Cys/CySS and 
GSH/GSSG pools.  
3.6. Antioxidant Protein Expression  
Although the measurement of liver Cys/CySS and GSH/GSSG pools do not provide evidence of 
oxidative stress in the pair-fed group, these measures do not discriminate between effects in different 
subcellular compartments. Because oxidative stress can cause specific responses in subcellular 
compartments, we assessed the compartmental effects of fructose and glucose by measuring the 
abundance of mitochondrial Trx2 and cytoplasmic/nuclear Prx2. The abundance of these key 
compartment-specific antioxidant proteins was assessed using Western blotting. When normalized to 
β-actin (Figure 6a), Trx2 abundance was significantly lower in the fructose-fed and glucose-fed groups 
(23% and 20% lower) respectively, compared to control (Figure 6b). In contrast to that of the 
carbohydrate fed mice, the pair-fed group had significantly higher (150%) abundance of hepatic Trx2 
compared to control. No difference was observed for the cytoplasmic antioxidant Prx2. Measurement 
of a component of the mitochondrial respiratory apparatus, cytochrome c oxidase IV (COX-IV) was 
used as a control for mitochondrial abundance, and this showed that the content of mitochondria did 
not differ among the groups. 
  
T
B
A
R
S
 
(
μ
M
o
l
/
m
g
 
p
r
o
t
e
i
n
)
Control  Fructose Glucose Pair-fed
0.0
0.1
0.2
0.3
0.4
NS
N=7 N=7 N=8 N=7N
4
d
m
w
e
c
a
in
Nutrients 20
Figure
in the 
well 
(mitoc
abund
fructos
abund
fed (15
to oxi
statisti
4. Discussio
In the p
decreased su
model of fa
with only su
energy intak
compared to
and showed
nsufficiency
011, 3  
e 6. (a) We
liver in diff
as indicate
chondrial co
ance signif
se and gluc
ance decrea
50%) group
idative stre
ically signif
on 
present stud
ulfur amino
atty liver. B
ulfur amino 
ke compare
o controls. P
d increased 
y is not the
C
stern blots o
ferent study
ed by sim
ontrol) indi
fies no oxid
ose but incr
ased in fruct
p compared 
ess in fruc
ficant differ
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
T
r
x
2
/
β
-
a
c
t
i
n
 
f
l
u
o
r
o
s
e
n
c
e
dy, we use
o acid intak
Both fructos
acid defici
d to contro
Pair-fed ani
Trx2 abun
e cause of o
Control Fruc
of mitochon
y groups. Eq
milar  β-act
icated equa
dative stress
reased in pa
tose (77%) 
to control (
ctose and g
rence among
Normal
Control F
n=8      
a
d a contro
ke contribut
se and gluc
ency did no
l and displa
imals had s
ndance in li
oxidative st
ctose Glucos
ndrial (Trx2
qual amount
in abundan
al loading o
s in cytopla
air fed group
and glucose
(100%). Thi
glucose gro
g respective
(a) 
lized Trx-2
Fructose  G
     n=8          
b
(b) 
olled, pair-f
tes to oxida
ose-fed mic
ot. Fructose
ayed a simi
similar sulfu
iver. Toget
tress in the 
se Pair-fed
2) and cytop
ts of protein
nce. Simil
of mitocho
asm. Trx2 
p; (b) When
e (80%) gro
is indicates 
oups. Diffe
e groups. 
 
2 express
Glucose Pa
  n=8           n
b
feeding pro
ative stress
ce develope
e-fed and glu
ilar decrease
ur amino ac
ther, the re
models of 
plasmic (Prx
n were loade
lar abunda
ondrial prot
abundance 
n normalize
oups while i
mitochond
erent letter
sion
air fed
n=8
c
otocol to te
in an fructo
ed fatty live
ucose-fed a
e in hepatic
cid intake a
sults show 
fructose-sw
x2) redox p
ed (20 µg) i
ance of C
tein. Simila
was decrea
ed to β-actin
it increased 
drial predisp
s (a,b,c) in
 
est the hyp
ose-sweeten
er, but anim
animals had
c Trx2 abun
as the fructo
that sulfur
weetened liq
99
proteins 
in each 
OX-IV 
ar Prx2 
ased in 
n, Trx2 
in pair 
position 
ndicate 
pothesis tha
ned beverag
mals pair-fe
d similar tota
ndance whe
ose-fed mic
r amino aci
quid-induce
 
96
at 
ge 
ed 
al 
en 
e, 
id 
ed Nutrients 2011, 3  
 
997
fatty liver. Instead, the results suggest that disproportionately high energy intake from simple sugar  
(48% and 63% of total energy intake in fructose-fed and glucose-fed mice) may predispose 
mitochondria to oxidative stress. The carbohydrate-mediated decrease in Trx2 abundance is potentially 
important in terms of cell viability and liver damage, because Trx2 protects against oxidant-mediated 
apoptosis and can regulate the mitochondrial permeability transition [56,57]. 
Fructose-sweetened beverage intake is associated with decreased solid food and protein ingestion in 
obese and normal weight human subjects [34]. Raben et al. [35] showed a significant decrease in 
protein intake after consumption of sucrose-containing liquid. In rodents, Jurgens et al. [45] showed 
that after ad libitum fructose-containing liquid consumption, solid food intake was decreased, but total 
energy consumption was the same as controls. Our data are consistent with these previous studies 
showing that fructose-sweetened liquid consumption is associated with decreased solid food 
consumption, thus leading to insufficient sulfur amino acid intake. Deficiency of methionine, an 
essential amino acid, has been implicated in alcoholic liver disease and liver cirrhosis [10], secondary 
to its important role as a precursor of GSH. However, the potential role of dietary methionine in the 
pathogenesis of fatty liver does not appear to have been previously studied. 
Our results on hepatic TG content are similar to those of Ngo Sock et al. [58], who recently showed 
that hepatic TG content was similar in glucose and fructose-fed rodents. Several metabolic effects of 
high-fructose diet such as obesity, fatty liver, and insulin resistance can also be observed with   
high-glucose diet [32,58–61]. Also, in the long term, the effects of high fructose and high glucose may 
not be different. As fructose-sweetened beverage consumption is associated with high energy 
intake [58,59,62], it is unclear whether these hyperenergetic conditions can account for the metabolic 
effects of fructose [58,59].  
Most of the studies on fructose-sweetened liquid and fatty liver use products of lipid peroxidation as 
markers of oxidative stress and only few studies have evaluated enzymatic antioxidant systems [32,63]. 
To our knowledge, this is the first study evaluating hepatic mitochondrial and cytoplasmic antioxidant 
proteins and calculating the redox potentials of major thiol-disulfide couples in fructose-sweetened liquid 
model of fatty liver. Sumida et al. [64] showed a correlation between serum Trx levels and hepatic fat 
content in patients with fatty liver and proposed its usefulness in discriminating fatty liver from 
NASH. That study did not, however, evaluate hepatic Trx levels or specific Trx isoenzymes. Our study 
measured Trx2 abundance, which was decreased due to fructose and glucose feeding. These results 
suggest a predisposition to mitochondrial oxidative stress, which could be a pathogenic mechanism of 
fatty liver. This is different from a rodent study by Mellor et al. [25], which did not reveal any difference 
in myocardial Trx2 gene abundance due to a high fructose (60%) diet. This discrepancy could be 
explained by metabolic differences in these two organs as fructose is primarily metabolized in liver.  
Machado et al. [63] showed that in patients with fatty liver, GSH metabolism is impaired towards 
oxidation, but plasma antioxidant markers do not correlate with hepatic redox states. We measured 
plasma redox potentials along with liver redox potentials to assess if there was any correlation between 
these two compartments. In our pair-fed group, hepatic EhCySS was reduced and Trx2 abundance 
increased; however plasma EhCySS was oxidized compared to control. These differences indicate that 
the redox compartments may act independently of each other [46]. Opposite redox effects in plasma and 
liver may be explained by energy restriction (40% of control in our study) leading to decreased 
metabolism in liver, which may result in less reactive oxygen species (ROS) formation in mitochondria. Nutrients 2011, 3  
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Alternatively, energy restriction can induce mitohormesis; an increased formation of ROS within 
mitochondria that causes an adaptive response providing stress resistance with a long-term reduction of 
oxidative stress [65]. Lastly, with the pair-fed animals being protein and energy restricted, they 
exhibited lower sulfur amino acid levels in both plasma and the liver. This can be explained by a 
marked reduction in protein synthesis and increase in protein half-lives; therefore, a lack of protein 
intake and decreased protein turnover could result in lower levels of tissue and circulating amino acids.  
When comparing fructose-fed animals to glucose-fed animals, both groups had similar sulfur amino 
acid intake, total caloric intake, plasma and liver redox states and decrease in hepatic Trx2 abundance. 
A predisposition to hepatic mitochondrial oxidative stress as suggested by decreased Trx2 may be due 
to disproportionate energy intake from simple sugars, rather than decreased sulfur amino acid intake.  
One of the limitations of our study was the design of the pair-fed group. We matched the fructose 
group for solid food intake but not for total energy intake. Because the restricted diet intake in the  
pair-fed animals also reduced caloric intake, a more precise design for the sulfur amino acid effect 
would be to supplement the diet composition of the pair-fed control group with non-carbohydrate 
energy sources (e.g., lipid) such that caloric intake in all four groups was similar. Future experiments 
with matched pair feeding according to macronutrient composition could potentially improve the 
models for fructose-sweetened liquid-induced fatty liver.  
5. Conclusion 
Fructose-sweetened liquid predisposes the liver to mitochondrial oxidative stress and causes fatty 
liver without plasma or cytoplasmic oxidative stress. The hypocaloric, pair-fed group displayed plasma, 
but not hepatic oxidative stress or fatty liver. Therefore, decreased sulfur amino acid intake, as occurs in 
models commonly used to study fructose-induced fatty liver, is not a cause of hepatic oxidative stress in 
this model and does not provide an explanation for fructose-induced lipid accumulation in this model.  
Implications 
The study rules out a potential artifact of an important model used to study fructose-induced fatty 
liver. The study additionally shows the potential importance of mitochondrial oxidative stress in 
pathogenesis of fructose-induced fatty liver and that fructose and glucose-sweetened beverages may 
have similar hepatic metabolic, as evidenced by the equivalent liver TG outcomes, and redox effects.  
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